Business Context and Reporting Period
Nano-X Imaging Ltd. furnished this Form 6-K for January 2024. The filing reports the results of the Company’s annual general meeting held on December 31, 2023, at its offices in Israel.
Key Financial Metrics and Capital Structure
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating and financial metrics.
Material Changes Versus the Prior Comparable Period
- Shareholders approved the re-election of Ran Poliakine, Dan Suesskind, and So Young Shin as Class III directors, each to serve until the 2026 annual general meeting and until a successor is elected and qualified.
- Nehama Ronen was elected as a Class I director for a one-year term ending at the 2024 annual general meeting, subject to successor qualification.
- Shareholders approved option awards to the non-executive directors serving immediately after the meeting.
- Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International Limited, was re-appointed as the independent registered public accounting firm for the fiscal year ending December 31, 2023, and until the next annual general meeting.
Guidance, Outlook, Risks, and Unusual Items
The filing contains no management guidance, business outlook, risk updates, contingencies, or unusual financial items. It states that the report is incorporated by reference into the Company’s Form F-3 and Form S-8 registration statements.
Investor Verification Items
- Verify the composition and terms of the Company’s board following the annual general meeting.
- Review the terms and potential dilution associated with the approved non-executive director option awards.
- Confirm the auditor’s appointment and the scope of the audit for the year ended December 31, 2023.
- Consult the Company’s annual report and other filings for financial performance, liquidity, debt, operating results, and forward-looking information not included in this Form 6-K.